The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

X.l

Myopathy-Myositis-Polymyositis (see also under Xba)

Publications

Kato M, Oiso N, Nozaki Y, Inoue A, Hosono Y, Funauchi M, Mimori T, Matsumura I, Kawada A

Antitumor necrosis factor alpha inhibitor-induced dermatomyositis and interstitial lung disease with anti-PL12 autoantibody: signs of antisynthetase syndrome.

The Journal of dermatology 2014 Nov;41;1034-6 — 2014 Nov — 1034-6

Klein R, Rosenbach M, Kim EJ, Kim B, Werth VP, Dunham J

Tumor necrosis factor inhibitor-associated dermatomyositis.

Archives of dermatology 2010 Jul;146;780-4 — 2010 Jul — 780-4